Full Text View
Tabular View
No Study Results Posted
Related Studies
Sitagliptin vs Glipizide in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency
This study is currently recruiting participants.
Study NCT00509262   Information provided by Merck
First Received: July 27, 2007   Last Updated: October 28, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Type 2 Diabetes Mellitus
Renal Insufficiency, Chronic
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 2
Renal Insufficiency
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Kidney Diseases
Metabolic Diseases
Urologic Diseases
Interventions listed in this trial
Comparator: sitagliptin phosphate
Comparator: Comparator: glipizide
Additional drug interventions recognized in this trial
Glipizide
Sitagliptin
More general drug interventions related to this trial
Dipeptidyl-Peptidase IV Inhibitors
Enzyme Inhibitors
Hypoglycemic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services